- KR₩24bn
- KR₩29bn
- KR₩35bn
- 32
- 46
- 40
- 30
Annual balance sheet for XCure, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17,844 | 11,685 | 16,014 | 16,416 | 9,018 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,426 | 1,503 | 2,174 | 1,481 | 12,093 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 21,537 | 17,506 | 19,428 | 20,040 | 27,109 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 630 | 572 | 798 | 965 | 1,847 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 25,282 | 24,589 | 25,636 | 26,020 | 48,948 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,856 | 1,959 | 1,888 | 1,020 | 23,181 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,970 | 2,247 | 2,113 | 1,487 | 27,428 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 23,312 | 22,342 | 23,523 | 24,533 | 21,521 |
Total Liabilities & Shareholders' Equity | 25,282 | 24,589 | 25,636 | 26,020 | 48,948 |
Total Common Shares Outstanding |